Zakai Neil A, Ohira Tetsuya, White Richard, Folsom Aaron R, Cushman Mary
Department of Medicine, Brown University and Boston University, Providence, RI, USA.
Am J Med. 2008 Mar;121(3):231-8. doi: 10.1016/j.amjmed.2007.10.025.
Lower activated partial thromboplastin times are associated with higher levels of some coagulation factors and may represent a procoagulant tendency.
In the Atherosclerosis Risk in Communities study, we studied the 13-year risk of venous thromboembolism in relation to baseline activated partial thromboplastin time in 13,880 individuals. We also studied 258 venous thromboembolism cases and 589 matched controls with measurements of additional coagulation factors.
After adjustment for demographics and procoagulant factors reflected in the activated partial thromboplastin time (fibrinogen, factors VIII, IX, and XI, and von Willebrand factor), participants in the lowest 2 quartiles of activated partial thromboplastin time compared with the fourth quartile had 2.4-fold (95% confidence interval [CI], 1.4-4.2) and 1.9-fold (95% CI, 1.1-3.2) higher risks of venous thromboembolism. The risk associated with activated partial thromboplastin times below the median was higher for idiopathic (odds ratio 5.5; 95% CI, 2.0-15.5) than secondary venous thromboembolism (odds ratio 1.74; 95% CI, 0.88-3.43). Subjects with both activated partial thromboplastin times below the median and factor V Leiden were 12.6-fold (95% CI, 5.7-28.0) more likely to develop venous thromboembolism compared with those with neither risk factor (P interaction<.01). A lower activated partial thromboplastin time also added to the thrombosis risk associated with obesity and elevated D-dimer.
A single determination of the activated partial thromboplastin time below the median increased the risk of future venous thromboembolism. Findings were independent of coagulation factor levels, and a low activated partial thromboplastin time added to the risk associated with other risk factors.
活化部分凝血活酶时间降低与某些凝血因子水平升高相关,可能代表促凝倾向。
在社区动脉粥样硬化风险研究中,我们研究了13880名个体的基线活化部分凝血活酶时间与13年静脉血栓栓塞风险之间的关系。我们还研究了258例静脉血栓栓塞病例和589例匹配对照,并测量了其他凝血因子。
在对人口统计学和活化部分凝血活酶时间所反映的促凝因子(纤维蛋白原、因子VIII、IX和XI以及血管性血友病因子)进行调整后,活化部分凝血活酶时间处于最低两个四分位数的参与者与第四四分位数相比,静脉血栓栓塞风险分别高2.4倍(95%置信区间[CI],1.4 - 4.2)和1.9倍(95%CI,1.1 - 3.2)。活化部分凝血活酶时间低于中位数时,特发性静脉血栓栓塞(比值比5.5;95%CI,2.0 - 15.5)的风险高于继发性静脉血栓栓塞(比值比1.74;95%CI,0.88 - 3.43)。活化部分凝血活酶时间低于中位数且携带因子V莱顿突变的受试者与无这两种危险因素的受试者相比,发生静脉血栓栓塞的可能性高12.6倍(95%CI,5.7 - 28.0)(P交互作用<.01)。较低的活化部分凝血活酶时间也增加了与肥胖和D - 二聚体升高相关的血栓形成风险。
单次测定活化部分凝血活酶时间低于中位数会增加未来静脉血栓栓塞的风险。研究结果与凝血因子水平无关,且低活化部分凝血活酶时间会增加与其他危险因素相关的风险。